Loading...

Marine Compounds Will Transform Personalized Cancer Treatment Globally

Published
20 Jul 25
AnalystHighTarget's Fair Value
€118.00
21.2% undervalued intrinsic discount
10 Sep
€93.00
Loading
1Y
99.6%
7D
5.4%

Author's Valuation

€11821.2% undervalued intrinsic discount

AnalystHighTarget Fair Value